Actin genes and protein abundance for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Gene abundance for α-integrins for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Abiotic factors affect the average proportion of various bacterial functional groups. by Rachel L. Spietz (782905)

Long-term sucrose intake (12 weeks) increases α4(nonα6)β2* nAChR and decreases α6β2* nAChR levels in rat nucleus accumbens (NAc). by Masroor Shariff (2583442)

“…<p>Quantitative analyses of α4(nonα6)β2* nAChR binding using ¹²⁵I-Epibatidine binding in the absence and presence of α-CtxMII show show a significant increase in α4(nonα6)β2* nAChRs (A and B) with a decrease in α6β2* nAChRs (C and D) after short-term (4 week) and long-term (12 week) sucrose exposure in the intermittent-access two-bottle choice paradigm. …”

PBMCs from IL23R^Q381 positive donors have decreased IL23R surface expression and reduced IL-23 responsiveness compared to IL23R^R381. by Svetlana Pidasheva (201304)

Study design and bodyweight evolution. by Rodrick Montjean (400649)

Gene and protein abundance for Bcl-2, CAV1, CCND1 and PAK6 for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Migration capacity of HPAEC and CTEPH-EC in basal and with HSP70 inhibitor VER-155008. by William Salibe-Filho (9727738)

Electrocardiographic parameters in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

Echocardiographic parameters in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

Effects of olmesartan on protein expression of angiotensin converting enzyme (ACE) isoforms and angiotensin II type 1 (AT₁) receptor. by Naoko Matsushita (113751)

Bacterial alpha-diversity varies by DO. by Rachel L. Spietz (782905)

Protein expression and specific activity of Glo-I in whole liver and specific activity of Glo-I in pHEP, pHSC and pLSEC in controls, early and advanced cirrhosis. by Marcus Hollenbach (376231)

General parameters and the incidence of premature ventricular contraction (PVC) in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

LM11A-31's effect on cholinergic dystrophic neurites in cortex of mid-stage APP^L/S mice. by Danielle A. Simmons (621167)

“…Scale bar in photomicrograph A = 50 µm. Quantitative analysis showed that LM11A-31 decreases the total area occupied by the clusters (<b><i>C</i></b>) by decreasing their number (<b><i>D</i></b>) but not the mean area per cluster (<b><i>E</i></b>). …”

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

Effects of olmesartan on the left ventricular fibrosis and on connective tissue growth factor (CTGF) and collagen type 1 gene expression. by Naoko Matsushita (113751)

Proteomic analysis of control, TGF-β1 model, and melatonin-treated HBdSMCs. by Yang Zhang (30734)

Hel2 and Asc1 attenuate gene expression from stall-containing mRNAs only at high initiation rates. by Heungwon Park (3859507)

Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC. by Marcus Hollenbach (376231)

“…Co-treatment of LPS and EP indicated significant dose-dependent reduction of LPS-induced markers of inflammation <b>(A1)</b> and fibrosis <b>(B1, C1)</b>. Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”